Bruton's Agammaglobulinaemia

Disease Overview

Bruton's Agammaglobulinaemia is a rare primary immunodeficiency disorder characterized by the absence or severe reduction of B lymphocytes and immunoglobulins, resulting in a profound impairment of the immune system's ability to fight infections.

Disease Category

Primary Immunodeficiency Disorder (Humoral Immunodeficiency)

Synonyms

• X-linked Agammaglobulinaemia (XLA)
• Congenital Agammaglobulinaemia
• Bruton's Hypogammaglobulinemia
• Sex-linked Agammaglobulinaemia

Signs & Symptoms

• Recurrent bacterial infections
• Increased susceptibility to respiratory tract infections
• Chronic sinusitis
• Repeated ear infections
• Pneumonia
• Gastrointestinal infections
• Skin infections
• Arthritis
• Delayed growth and development
• Absence of tonsils and lymph node enlargement
• Increased risk of autoimmune disorders
• Potential development of chronic lung disease

Causes

• Genetic mutation in the BTK (Bruton Tyrosine Kinase) gene
• X-linked recessive inheritance pattern
• Mutation prevents B cell maturation and antibody production
• Primarily affects males due to X-linked transmission

Affected Populations

• Predominantly males
• Incidence: Approximately 1 in 190,000 live births
• Typically diagnosed between 6 months and 5 years of age
• Occurs across all ethnic groups

Disorders with Similar Symptoms

• Common Variable Immunodeficiency (CVID)
• Severe Combined Immunodeficiency (SCID)
• Hyper IgM Syndrome
• Selective IgA Deficiency
• Chronic Granulomatous Disease

Diagnosis

• Comprehensive medical history
• Physical examination
• Blood tests measuring immunoglobulin levels
• Flow cytometry to assess B cell count
• Genetic testing for BTK gene mutations
• Immunological function tests
• Family history analysis

Standard Therapies

• Lifelong immunoglobulin replacement therapy
• Intravenous or subcutaneous immunoglobulin (IVIG/SCIG)
• Prophylactic antibiotics
• Regular medical monitoring
• Vaccination with inactivated vaccines
• Treatment of acute infections
• Potential gene therapy (experimental)

Clinical Trials and Studies

• Ongoing research in gene therapy
• Investigations into novel immunoglobulin replacement strategies
• Studies exploring long-term management techniques
• Genetic modification approaches
• Recommended resource: ClinicalTrials.gov

References

• National Institutes of Health (NIH)
• Immune Deficiency Foundation
• Primary Immunodeficiency Diseases: Molecular & Cellular Approach
• World Health Organization (WHO) Guidelines

Programs & Resources

• Immune Deficiency Foundation
• Jeffrey Modell Foundation
• National Organization for Rare Disorders (NORD)
• Genetic and Rare Diseases Information Center
• Patient support groups and online communities

Complete Report

A comprehensive understanding requires consultation with specialized immunology professionals and genetic counselors. Individualized medical assessment is crucial for comprehensive management.